
Normal Immunoglobulin (Human) 10% and Recombinant Human Hyaluronidase (HyQvia)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.415
Subject(s) - reimbursement , hyaluronidase , recombinant dna , antibody , medicine , drug , human immunodeficiency virus (hiv) , immunology , pharmacology , chemistry , enzyme , political science , biochemistry , health care , law , gene